Cryoballoon ablation for pulmonary vein isolation
Abstract Over the past 20 years, multiple studies have demonstrated the superiority of percutaneous catheter‐based pulmonary vein isolation (PVI) in the management of atrial fibrillation (AF). Unfortunately, the results of catheter ablation can be limited by arrhythmia recurrence, which is often a r...
| Published in: | Journal of Cardiovascular Electrophysiology |
|---|---|
| Main Author: | |
| Format: | Article in Journal/Newspaper |
| Language: | English |
| Published: |
Wiley
2020
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1111/jce.14459 https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjce.14459 https://onlinelibrary.wiley.com/doi/pdf/10.1111/jce.14459 https://onlinelibrary.wiley.com/doi/full-xml/10.1111/jce.14459 |
| Summary: | Abstract Over the past 20 years, multiple studies have demonstrated the superiority of percutaneous catheter‐based pulmonary vein isolation (PVI) in the management of atrial fibrillation (AF). Unfortunately, the results of catheter ablation can be limited by arrhythmia recurrence, which is often a result of a failure to achieve durable lesions around the pulmonary vein ostia. In response, significant efforts have been directed toward developing technologies to achieve safer and more durable PVI, including the development of dedicated catheters capable of achieving PVI with a single ablation lesion (eg, the Arctic Front Cryoballoon; Medtronic CryoCath, Pointe‐Claire, Canada). The purpose of this review is to discuss the contemporary role of cryoballoon ablation in the invasive management of AF, with a focus on the characteristics that differentiate cryoballoon from radiofrequency ablation. |
|---|